Ranolazine: a contemporary review
E Rayner‐Hartley, T Sedlak - Journal of the American Heart …, 2016 - Am Heart Assoc
Ranolazine, a piperazine derivative sold under the trade name Ranexa, is a well-tolerated
medication that selectively inhibits the late sodium current. Additionally, ranolazine has …
medication that selectively inhibits the late sodium current. Additionally, ranolazine has …
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the …
comprehensive review of the published evidence for management of a given condition
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …
Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST: Grupo de Trabajo de la Sociedad Europea de …
ACOanticoagulación oralACVCAssociation for Acute Cardiovascular CareAHAAmerican
Heart AssociationARC-HBRAcademic Research Consortium for High Bleeding …
Heart AssociationARC-HBRAcademic Research Consortium for High Bleeding …
[HTML][HTML] 2023 Guidelines of the Taiwan Society of Cardiology on the diagnosis and management of chronic coronary syndrome
KC Ueng, CE Chiang, TH Chao, YW Wu… - Acta Cardiologica …, 2023 - ncbi.nlm.nih.gov
Coronary artery disease (CAD) covers a wide spectrum from persons who are asymptomatic
to those presenting with acute coronary syndromes (ACS) and sudden cardiac death …
to those presenting with acute coronary syndromes (ACS) and sudden cardiac death …
Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo …
G Weisz, P Généreux, A Iñiguez, A Zurakowski… - The Lancet, 2016 - thelancet.com
Background Incomplete revascularisation is common after percutaneous coronary
intervention and is associated with increased mortality and adverse cardiovascular events …
intervention and is associated with increased mortality and adverse cardiovascular events …
[HTML][HTML] Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure
JJ Dalal, S Mishra - Indian Heart Journal, 2017 - Elsevier
The combined and relative contribution of glucose and fatty acid oxidation generates
myocardial energy, which regulates the cardiac function and efficiency. Any dysregulation in …
myocardial energy, which regulates the cardiac function and efficiency. Any dysregulation in …
Effects of ranolazine on angina and quality of life after percutaneous coronary intervention with incomplete revascularization: results from the ranolazine for incomplete …
KP Alexander, G Weisz, K Prather, S James, DB Mark… - Circulation, 2016 - Am Heart Assoc
Background—Angina often persists or returns in populations following percutaneous
coronary intervention (PCI). We hypothesized that ranolazine would be effective in reducing …
coronary intervention (PCI). We hypothesized that ranolazine would be effective in reducing …
Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure
Previous studies have shown that loss of CD36 protects the heart from dysfunction induced
by pressure overload in the presence of diet-induced insulin resistance and/or obesity. The …
by pressure overload in the presence of diet-induced insulin resistance and/or obesity. The …
Antibiotics: achieving the balance between access and excess
P Das, R Horton - The Lancet, 2016 - thelancet.com
Comment www. thelancet. com Vol 387 January 9, 2016 103 resource. Our Series defines
two dimensions: sustainable access, as well as sustainable effectiveness. The threat to …
two dimensions: sustainable access, as well as sustainable effectiveness. The threat to …
Objectives and Design of the Russian Acute Coronary Syndrome Registry (RusACSR)
VI Gridnev, AR Kiselev, OM Posnenkova… - Clinical …, 2016 - Wiley Online Library
ABSTRACT The Russian Acute Coronary Syndrome Registry (RusACSR) is a retrospective,
continuous, nationwide, Web‐based registry of patients with acute coronary syndromes …
continuous, nationwide, Web‐based registry of patients with acute coronary syndromes …